Skip to content
OpenCapital
Get started

Recursion Pharmaceuticals, Inc. RXRX D&A

D&A at other companies

Trinet Group logo
Trinet GroupTNET
$17M0.0%
WEX logo
WEXWEX
$37.9M+3.0%
Unifirst logo
UnifirstUNF
$35.39M+1.3%
Travel + Leisure logo
Travel + LeisureTNL
$32M+6.7%
HES
Hess MidstreamHESM
$58.5M+13.6%
Warrior Met Coal logo
Warrior Met CoalHCC
$52.27M+15.5%

Segments

By segment

See full
Reportable Segment$19.67M+1.8%

Other financials

Income statement

See full
Revenue$6.5M-56.1%
Gross profit-$6.0M+15.0%
Operating income-$128.5M+32.8%
Net income-$117.5M+42.0%
EPS (diluted)-$0.22+56.0%

Balance sheet

See full
Cash & equivalents$665.2M+30.6%
Total debt$88.6M-24.6%
Total equity$1.0B+9.7%
Total assets$1.3B+2.6%

Cash flow

See full
Operating cash flow-$81.1M+38.5%
CapEx$258.0K-85.9%
Free cash flow-$81.4M+39.2%

Valuation

See full
Market cap$1.71B-23.7%
Enterprise value$1.14B-39.8%
P/S25.8×-11.8×

Profitability

See full
Gross margin7.2%—
Operating margin-881.3%-66.8pp
Net margin-842.9%-92.4pp
FCF margin-490.7%-102pp

Returns & leverage

See full
Return on equity-57.2%-14.4pp
Debt / equity0.1×0.0×
Current ratio5.5×+1.4×